Clorox (CLX) Stock Forecast, Price & News

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clorox in the last twelve months. There are currently 6 sell ratings, 7 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" CLX shares.
View CLX analyst ratings or view top-rated stocks.

14 analysts have issued 1 year target prices for Clorox's shares. Their CLX share price forecasts range from $127.00 to $185.00. On average, they predict the company's stock price to reach $147.64 in the next twelve months. This suggests a possible upside of 11.3% from the stock's current price.
View analysts price targets for CLX or view top-rated stocks among Wall Street analysts.

Clorox's stock was trading at $140.33 at the beginning of 2023. Since then, CLX shares have decreased by 5.5% and is now trading at $132.66.
View the best growth stocks for 2023 here.

Clorox saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 3,860,000 shares, a decline of 12.9% from the August 15th total of 4,430,000 shares. Based on an average daily trading volume, of 1,170,000 shares, the short-interest ratio is currently 3.3 days. Approximately 3.1% of the shares of the stock are sold short.
View Clorox's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our CLX earnings forecast.

The Clorox Company (NYSE:CLX) posted its quarterly earnings data on Wednesday, August, 2nd. The company reported $1.67 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.48. The firm had revenue of $2.02 billion for the quarter, compared to the consensus estimate of $1.88 billion. Clorox had a net margin of 2.02% and a trailing twelve-month return on equity of 163.56%. The company's quarterly revenue was up 12.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.93 EPS.
Read the conference call transcript.

Clorox announced a quarterly dividend on Wednesday, September 20th. Stockholders of record on Wednesday, October 25th will be given a dividend of $1.20 per share on Thursday, November 9th. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.62%. The ex-dividend date is Tuesday, October 24th.
Read our dividend analysis for CLX.

ETFs with the largest weight of Clorox (NYSE:CLX) stock in their portfolio include Natixis Vaughan Nelson Select ETF (VNSE), Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS), 2ndVote Society Defended ETF (EGIS), Invesco S&P 500 Equal Weight Consumer Staples ETF (RHS), VanEck Morningstar ESG Moat ETF (MOTE), Victoryshares Dividend Accelerator ETF (VSDA), ProShares Russell US Dividend Growers ETF (TMDV) and SPDR S&P Dividend ETF (SDY).

Clorox (NYSE:CLX) pays an annual dividend of $4.80 per share and currently has a dividend yield of 3.52%. The company has been increasing its dividend for 37 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 403.36%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, CLX will have a dividend payout ratio of 73.39% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLX.

Clorox updated its FY 2024 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of $5.60-$5.90 for the period, compared to the consensus EPS estimate of $5.63. The company issued revenue guidance of $7.39 billion-$7.54 billion, compared to the consensus revenue estimate of $7.45 billion.

17 employees have rated Clorox Chief Executive Officer Linda Rendle on Glassdoor.com. Linda Rendle has an approval rating of 94% among the company's employees. This puts Linda Rendle in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Clorox investors own include Johnson & Johnson (JNJ), AbbVie (ABBV), NVIDIA (NVDA), Verizon Communications (VZ), AT&T (T), Walt Disney (DIS), Home Depot (HD), Procter & Gamble (PG), Intel (INTC) and JPMorgan Chase & Co. (JPM).

Clorox trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLX."

Clorox's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.03%), State Street Corp (6.48%), Geode Capital Management LLC (2.28%), Stifel Financial Corp (1.73%), Wells Fargo & Company MN (1.30%) and Northern Trust Corp (1.29%). Insiders that own company stock include A D David Mackay, Benno O Dorer, Diego J Barral, Eric H Reynolds, Kevin B Jacobsen, Laura Stein and William S Bailey.
View institutional ownership trends.

Shares of CLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLX stock can currently be purchased for approximately $132.66.

Clorox (NYSE:CLX) has a market capitalization of $16.43 billion and generates $7.39 billion in revenue each year. The company earns $149 million in net income (profit) each year or $1.19 on an earnings per share basis.

The company employs 8,700 workers across the globe.

Clorox's mailing address is 1221 BROADWAY, OAKLAND CA, 94612. The official website for the company is www.thecloroxcompany.com. The company can be reached via phone at (510) 271-7000, via email at investorrelations@clorox.com, or via fax at 510-832-1463.